Cargando…
Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion
Cannabis is being increasingly used as a medical treatment for a variety of illnesses. However, the cannabis plant has more than 70 different phytocannabinoids with potential pharmacologic activity. Two of the most researched phytocannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (...
Autores principales: | Boggs, Douglas Lee, Peckham, Alyssa, Boggs, Angela A., Ranganathan, Mohini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007535/ https://www.ncbi.nlm.nih.gov/pubmed/29955482 http://dx.doi.org/10.9740/mhc.2016.11.277 |
Ejemplares similares
-
Glycinergic signaling in the human nervous system: An overview of therapeutic drug targets and clinical effects
por: Schmidt, Robert W., et al.
Publicado: (2016) -
Brain-derived neurotrophic factor and schizophrenia
por: Gören, Jessica L.
Publicado: (2016) -
Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile
por: Clemens, Andreas, et al.
Publicado: (2012) -
Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial
por: Pesic, Marija, et al.
Publicado: (2020) -
Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation
por: Tanigawara, Yusuke, et al.
Publicado: (2011)